Rahul Rajkumar
Biographic Data
| ID | 6084393 |
|---|---|
| NAME | Rahul Rajkumar |
| GIVEN NAMES | Rahul |
| FAMILY NAME | Rajkumar |
| SIGNATURE | RAJKUMAR R |
| AFFILIATIONS | Thomas R. Frieden is president and CEO of Resolve to Save Lives, an initiative of Vital Strategies, New York, NY. Rahul Rajkumar is COO of Care Solutions, Optum, Washington, DC. Farzad Mostashari is a visiting fellow at Duke-Margolis Center for Health Policy, Washington, DC, and CEO at Aledade, Inc., Bethesda, MD. |
| ORCID | 0000-0003-1949-6723 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
We Must Fix US Health and Public Health Policy
Despite a history of public health progress and the most expensive health care system in the world, the United States failed in its initial response to COVID-19. Much of this failure resulted from a presidential administration that sidelined, undermined, and maligned public health. But the roots of failure are deeper. Recovering from the pandemic and building health and public health back better will require recognizing the roots of failure and w…
Closing the access gap for health innovations
BACKGROUND: This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University, Gilead Sciences, and Royalty Pharma is used as an example to illustrate how 'equitable access licensing' could be put into practice. DISCUSSION: While the crisis of access to medicines in poor countries has mu…
No prominent works on this page.
Closing the access gap for health innovations
BACKGROUND: This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University, Gilead Sciences, and Royalty Pharma is used as an example to illustrate how 'equitable access licensing' could be put into practice. DISCUSSION: While the crisis of access to medicines in poor countries has mu…
We Must Fix US Health and Public Health Policy
Despite a history of public health progress and the most expensive health care system in the world, the United States failed in its initial response to COVID-19. Much of this failure resulted from a presidential administration that sidelined, undermined, and maligned public health. But the roots of failure are deeper. Recovering from the pandemic and building health and public health back better will require recognizing the roots of failure and w…
Political science (2 works) · Biotechnology and Related Fields (1 work) · Business (1 work) · Economic growth (1 work) · Economics (1 work) · Enforcement (1 work) · Environmental health (1 work) · Essential medicines (1 work) · Health care (1 work) · Health Policy (1 work)